Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
about
Current hepatitis B treatment guidelines and future research directions.Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional studyVirological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Evolution of hepatitis B serological markers in HIV coinfected patients: a case study.Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.Halofuginone ameliorates inflammation in severe acute hepatitis B virus (HBV)-infected SD rats through AMPK activation.
P2860
Q30487002-66C421B0-5912-4A08-8F8C-4840E759402FQ33734612-6BA72D9C-F144-46B2-BF27-2C7C16A4FF6AQ36235577-B54957CC-CCCE-4408-AC63-51C56008CC1DQ38918596-ACC51F16-289D-4190-86B0-92D3EEC4880AQ39425755-F5F01E99-00DB-43E5-936B-8BB84F3A2DA3Q39530695-9AB15951-C74D-41EF-A60F-51F3A8C0F18FQ40590338-86379DDD-EF6C-471E-9EA5-829ADAAA6859Q40736922-803A1546-FE81-4EB2-8F8A-289C1CF1DDF9Q42233095-90408C9E-04A9-4881-85AC-9540608CA916Q42688286-1A88F219-FC50-4FC7-A7FB-55797DD1ABBE
P2860
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@ast
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@en
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@nl
type
label
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@ast
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@en
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@nl
prefLabel
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@ast
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@en
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@nl
P2093
P2860
P50
P1433
P1476
Quantitative HBsAg and HBeAg p ...... IV-HBV coinfected individuals.
@en
P2093
Anchalee Avihingsanon
Gail V Matthews
Gregory J Dore
Joe Sasadeusz
Rachel Hammond
Rachel J Ali
Scott Bowden
Stephen L Locarnini
P2860
P304
P356
10.1371/JOURNAL.PONE.0061297
P407
P577
2013-04-09T00:00:00Z